System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Alis Ilie is an expert in Oncology at Centre Georges François Leclerc (France). Alis Ilie has authored 26 publications, the most recent in 2026. SLR score: 53 (community average: 125). How the SLR is computed.

LeadR Profile

Alis Ilie Centre Georges François Leclerc France
53 ScienceLeadR Reputation 53

Unlock

Register Login
Network Map

Oncology

Subspecialties: Immunology - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2019 - 2026
Source: PubMed

University of Burgundy

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 26

Citations

Citations: 124 1st author: 0 Last author: 0 Unique author: 0

Main journals

Morphologie 3
EBioMedicine 2
Eur J Cancer 2
Front Immunol 2
Oncoimmunology 2

Best Journals

Ann Oncol 1
J Clin Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Deep learning based on CD3 histological slides for prediction of colon cancer outcome: analysis of three international stage III colon cancer cohorts.
PMID 42100890 — neoplasms, colon, biomarkers, deep learning, therapeutics, learning, prognosis, colonic neoplasms		Oncoimmunology20260
Corrigendum to "Combination of CDX2H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer" [In European Journal of Cancer, Volume 172, 2022, Pages 221-230, ISSN 0959-8049].
PMID 41946180 — neoplasms, colon, artificial intelligence, prognosis, colonic neoplasms		Eur J Cancer20260
Deep learning-based assessment of PD-L1 expression in NSCLC predicts outcome for patients treated with anti-PD-1 immunotherapy.
PMID 41766864 — lung, neoplasms, carcinoma, non-small-cell lung, biomarkers, immunotherapy, immune system diseases, deep learning, therapeutics, learning		Front Immunol20260
Cancer cell-derived IL-1β reverses chemo-immunotherapy resistance in non-small cell lung cancer.
PMID 41271647 — cells, lung, biological science disciplines, neoplasms, carcinoma, non-small-cell lung, immunotherapy, dna, mitochondrial, lung neoplasms, small cell lung carcinoma		Nat Commun20250
Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T Cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite Stable Colorectal Cancer.
PMID 41196020 — cytokines, cells, microsatellite repeats, macrophages, neoplasms, therapeutics, colorectal neoplasms, t-lymphocytes, tumor-associated macrophages, dinoprostone		Cancer Res20253

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS